OpenAI released an early version of a model specifically designed to accelerate drug discovery. This move puts the company in direct competition with Google in the biotech sector. The tool aims to shorten the timeline for scientific breakthroughs. Practitioners can now leverage these models to identify viable drug candidates faster than traditional methods.